BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33000236)

  • 21. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
    Cao J; Huang W
    Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.
    Ehmer U; Sage J
    Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP and the Hippo pathway in cholangiocarcinoma.
    Sugihara T; Isomoto H; Gores G; Smoot R
    J Gastroenterol; 2019 Jun; 54(6):485-491. PubMed ID: 30815737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
    Wang J; Martin JF
    J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Hippo Pathway in Fibrosis and Cancer.
    Kim CL; Choi SH; Mo JS
    Cells; 2019 May; 8(5):. PubMed ID: 31100975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP and TAZ: a nexus for Hippo signaling and beyond.
    Hansen CG; Moroishi T; Guan KL
    Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
    Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
    Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity.
    White SM; Murakami S; Yi C
    Oncogene; 2019 Apr; 38(16):2899-2909. PubMed ID: 30617303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
    Werneburg N; Gores GJ; Smoot RL
    Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
    Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E
    EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel role of Hippo-YAP/TAZ in immunity at the mammalian maternal-fetal interface: Opportunities, challenges.
    Huang Z; Zhou J; Leung WT; Gober HJ; Pan X; Li C; Li L; Wang L
    Biomed Pharmacother; 2020 Jun; 126():110061. PubMed ID: 32145593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properly dividing with YAP.
    Pfeifer GP
    Sci Signal; 2016 Mar; 9(417):fs3. PubMed ID: 26933061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.
    Ouyang T; Meng W; Li M; Hong T; Zhang N
    Cell Mol Neurobiol; 2020 May; 40(4):495-510. PubMed ID: 31768921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.